Research Article
The Effect of Weight Loss in Obese Patients with Chronic Stable Plaque-Type Psoriasis
Table 4
Serum variables for the study population at baseline and weeks 12 and 24.
| | | Baseline | Week 12 | Week 24 |
| | Mean hemoglobin, mg/dL (SD) | 14.5 (1.0) | 14.2 (0.9) | 14.3 (1.3) | | AST, U/L (SD) | 34.6 (12.5) | 23.3 (7.7)* | 22.1 (4.8)** | | ALT, U/L (SD) | 57.1 (26.2) | 40.0 (6.5)* | 38.4 (7.2) | | Creatinine, mg/dL (SD) | 1.01 (0.2) | 0.8 (0.2)* | 0.9 (0.1)* | | Fasting blood sugar, mg/dL (SD) | 116.2 (33.5) | 104.8 (18.1) | 108.7 (26.8) | | HbA1c, % (SD) | 5.9 (2.5) | 6.1 (0.7) | 5.8 (0.6) | | Triglyceride, mg/dL (SD) | 157.9 (83.2) | 100.2 (45.3)** | 93.5 (34.5)* | | Total cholesterol, mg/dL (SD) | 193.9 (34.7) | 175.4 (29.6) | 205.4 (33.5) | | HDL cholesterol, mg/dL (SD) | 43.5 (8.9) | 44.9 (7.0) | 49.3 (10.6)* | | LDL cholesterol, mg/dL (SD) | 124.0 (29.4) | 110.1 (26.3)* | 136.5 (34.9) | | LDL : HDL cholesterol ratio (SD) | 2.9 (0.8) | 2.4 (0.6)* | 2.8 (0.8) | | hs-CRP, mg/dL (SD) | 5.9 (4.2) | 5.6 (5.9) | 5.6 (6.4) | | ESR, mm/hr (SD) | 20.9 (10.6) | 19.0 (8.8) | 16.3 (9.7) |
|
|
compared with baseline.
compared with baseline.
|
